BenjaminNLockshinMDFAAD(He/Him)

Dermatology • Silver Spring, MD

DermAssociates, PC

Join to view full profile

Dr. Lockshin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lockshin's full profile

Already have an account?

Office
10313 Georgia Ave
Ste 309
Silver Spring, MD 20902
Phone+1 301-681-7000

Education & Training

Indiana University School of MedicineResidency, Dermatology, 2003 - 2005
Georgetown University HospitalResidency, Dermatology, 2002 - 2003
MedStar Health/Georgetown University HospitalInternship, Internal Medicine, 2001 - 2002
Georgetown University School of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2024 - Present
MI State Medical License 2024 - 2027
TN State Medical License 2024 - 2027
CA State Medical License 2024 - 2026
WV State Medical License 2024 - 2026
IL State Medical License 2024 - 2026
VA State Medical License 2018 - 2026
TX State Medical License 2024 - 2026
MD State Medical License 2005 - 2026
OK State Medical License 2024 - 2026
MT State Medical License 2024 - 2025
WY State Medical License 2024 - 2025
WI State Medical License 2024 - 2025
WA State Medical License 2024 - 2025
NV State Medical License 2024 - 2025
KY State Medical License 2024 - 2025
IN State Medical License 2024 - 2025
ID State Medical License 2024 - 2025
GA State Medical License 2024 - 2025
CO State Medical License 2024 - 2025
AZ State Medical License 2024 - 2025
NE State Medical License 2024 - 2024
AL State Medical License 2024 - 2024
OH State Medical License 2005 - 2006
American Board of Dermatology Dermatology
Join now to see all

Awards, Honors, & Recognition

Resident Teaching Award Johns Hopkins University, Dept of Dermatology, 2011-2012
Top Doctors:Washington DC Area Castle Connolly, 2012
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Most Compassionate Doctor American Registry
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery
Join now to see all

Clinical Trials

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis Start of enrollment: 2006 Apr 01
Completed
Phase 2
Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis Start of enrollment: 2009 Dec 01
Completed
Phase 2
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) Start of enrollment: 2012 May 18
Completed
Phase 3
P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2012 Aug 01
Terminated
Phase 3
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa Start of enrollment: 2013 May 01
Terminated
Phase 2
Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2013 May 01
Completed
Phase 2
A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis Start of enrollment: 2013 Oct 01
Completed
Phase 1, Phase 2
Open-label Study of Dupilumab in Patients With Atopic Dermatitis Start of enrollment: 2013 Oct 10
Completed
Phase 3
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis Start of enrollment: 2014 Mar 01
Completed
Phase 3
Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis Start of enrollment: 2014 May 01
Completed
Phase 1, Phase 2
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2014 Sep 01
Completed
Phase 3
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis Start of enrollment: 2015 Jan 01
Completed
Phase 4
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2014 Oct 01
Completed
Phase 3
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis.
Andrew F Alexis, Melinda Gooderham, Shawn G Kwatra, Ahmad Amin, Susan Taylor
Dermatology and Therapy. 2024-10-01
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of ...
Eric L Simpson, Laurent Eckert, Abhijit Gadkari, T Michelle Brown, Peter A Lio
The British Journal of Dermatology. 2024-05-17
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clea...
Michael J Cork, Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel
Acta Dermato-Venereologica. 2024-02-12

Press Mentions

U.S. Dermatology Partners Expands Further in Virginia by Partnering with Robert Silverman, M.D.February 15th, 2018
20th Annual DC Lupus SummitMarch 19th, 2016